THRD

Third Harmonic Bio, Inc. - Common Stock (THRD)

About Third Harmonic Bio, Inc. - Common Stock (THRD)

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.

Details

Daily high
$5.15
Daily low
$5.12
Price at open
$5.12
52 Week High
$16.94
52 Week Low
$3.18
Market cap
231.9M
Dividend yield
0.00%
Volume
1,162
Avg. volume
1.2M
P/E ratio
-4.74

Third Harmonic Bio, Inc. - Common Stock News

Details

Daily high
$5.15
Daily low
$5.12
Price at open
$5.12
52 Week High
$16.94
52 Week Low
$3.18
Market cap
231.9M
Dividend yield
0.00%
Volume
1,162
Avg. volume
1.2M
P/E ratio
-4.74